ICU Medical Financial Statements (ICUI)
|
|
|
|
Report date
|
|
|
26.02.2021 |
25.02.2022 |
31.12.2022 |
27.02.2023 |
27.02.2024 |
|
12.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 271 |
1 316 |
2 280 |
2 280 |
2 259 |
|
2 340 |
|
Operating Income, bln rub |
|
|
41.8 |
52.4 |
-42.9 |
-8.70 |
22.8 |
|
0.468 |
|
EBITDA, bln rub |
? |
|
194.1 |
223.5 |
187.4 |
191.5 |
307.7 |
|
256.8 |
|
Net profit, bln rub |
? |
|
86.9 |
103.1 |
-154.5 |
-74.3 |
-29.7 |
|
-111.0 |
|
|
OCF, bln rub |
? |
|
222.8 |
267.5 |
-62.1 |
-62.1 |
166.2 |
|
255.1 |
|
CAPEX, bln rub |
? |
|
100.4 |
81.2 |
90.3 |
99.3 |
93.7 |
|
87.3 |
|
FCF, bln rub |
? |
|
122.4 |
186.4 |
-152.4 |
-161.5 |
72.5 |
|
167.8 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
11.5 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
-10.3% |
|
|
OPEX, bln rub |
|
|
325.9 |
350.2 |
740.7 |
701.3 |
717.0 |
|
752.9 |
|
Cost of production, bln rub |
|
|
809.5 |
824.8 |
1 582 |
1 582 |
1 519 |
|
1 586 |
|
R&D, bln rub |
|
|
42.9 |
47.5 |
93.0 |
93.0 |
85.3 |
|
88.7 |
|
Interest expenses, bln rub |
|
|
1.75 |
0.858 |
66.4 |
66.4 |
102.7 |
|
113.4 |
|
|
Assets, bln rub |
|
|
1 764 |
1 881 |
4 516 |
4 516 |
4 378 |
|
4 305 |
|
Net Assets, bln rub |
? |
|
1 502 |
1 616 |
2 090 |
2 090 |
2 123 |
|
2 049 |
|
Debt, bln rub |
|
|
52.1 |
45.0 |
1 653 |
1 653 |
1 705 |
|
1 594 |
|
Cash, bln rub |
|
|
410.8 |
567.2 |
213.0 |
213.0 |
254.7 |
|
312.5 |
|
Net debt, bln rub |
|
|
-358.6 |
-522.2 |
1 440 |
1 440 |
1 450 |
|
1 282 |
|
|
Ordinary share price, rub |
|
|
214.5 |
237.3 |
157.5 |
157.5 |
99.7 |
|
100.1 |
|
Number of ordinary shares, mln |
|
|
20.9 |
21.2 |
23.9 |
23.9 |
24.1 |
|
24.4 |
|
|
Market cap, bln rub |
|
|
4 484 |
5 033 |
3 759 |
3 759 |
2 403 |
|
2 446 |
|
EV, bln rub |
? |
|
4 126 |
4 511 |
5 199 |
5 199 |
3 853 |
|
3 728 |
|
Book value, bln rub |
|
|
1 272 |
1 384 |
-342 |
-342 |
-220 |
|
-216 |
|
|
EPS, rub |
? |
|
4.16 |
4.86 |
-6.47 |
-3.11 |
-1.23 |
|
-4.54 |
|
FCF/share, rub |
|
|
5.85 |
8.79 |
-6.39 |
-6.76 |
3.01 |
|
6.87 |
|
BV/share, rub |
|
|
60.8 |
65.3 |
-14.3 |
-14.3 |
-9.12 |
|
-8.82 |
|
|
EBITDA margin, % |
? |
|
15.3% |
17.0% |
8.22% |
8.40% |
13.6% |
|
11.0% |
|
Net margin, % |
? |
|
6.83% |
7.84% |
-6.78% |
-3.26% |
-1.31% |
|
-4.74% |
|
FCF yield, % |
? |
|
2.73% |
3.70% |
-4.06% |
-4.30% |
3.02% |
|
6.86% |
|
ROE, % |
? |
|
5.78% |
6.38% |
-7.39% |
-3.55% |
-1.40% |
|
-5.42% |
|
ROA, % |
? |
|
4.93% |
5.48% |
-3.42% |
-1.65% |
-0.68% |
|
-2.58% |
|
|
P/E |
? |
|
51.6 |
48.8 |
-24.3 |
-50.6 |
-81.0 |
|
-22.0 |
|
P/FCF |
|
|
36.6 |
27.0 |
-24.7 |
-23.3 |
33.1 |
|
14.6 |
|
P/S |
? |
|
3.53 |
3.82 |
1.65 |
1.65 |
1.06 |
|
1.05 |
|
P/BV |
? |
|
3.53 |
3.64 |
-11.0 |
-11.0 |
-10.9 |
|
-11.3 |
|
EV/EBITDA |
? |
|
21.3 |
20.2 |
27.7 |
27.1 |
12.5 |
|
14.5 |
|
Debt/EBITDA |
|
|
-1.85 |
-2.34 |
7.69 |
7.52 |
4.71 |
|
4.99 |
|
|
R&D/CAPEX, % |
|
|
42.8% |
58.5% |
103.0% |
93.6% |
91.1% |
|
101.6% |
|
|
CAPEX/Revenue, % |
|
|
7.90% |
6.17% |
3.96% |
4.36% |
4.15% |
|
3.73% |
|
| ICU Medical shareholders |
